Vanguard Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.02B | Buy |
|
|||||
|
2023
Q3 | $542M | Buy |
|
|||||
|
2023
Q2 | $672M | Buy |
|
|||||
|
2023
Q1 | $548M | Buy |
|
|||||
|
2022
Q4 | $541M | Buy |
|
|||||
|
2022
Q3 | $590M | Buy |
|
|||||
|
2022
Q2 | $275M | Buy |
|
|||||
|
2022
Q1 | $269M | Buy |
|
|||||
|
2021
Q4 | $273M | Buy |
|
|||||
|
2021
Q3 | $253M | Buy |
|
|||||
|
2021
Q2 | $230M | Buy |
|
|||||
|
2021
Q1 | $230M | Buy |
|
|||||
|
2020
Q4 | $124M | Buy |
|
|||||
|
2020
Q3 | $92.2M | Buy |
|
|||||
|
2020
Q2 | $122M | Buy |
|
|||||
|
2020
Q1 | $36.3M | Buy |
|
|||||
|
2019
Q4 | $32.4M | Buy |
|
|||||
|
2019
Q3 | $3.62M | Buy |
|
|||||
|
2019
Q2 | $1.29M | Buy |
|